Barbier Ann 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Jun 23, 2023
Insider Transaction Report
Form 4
Barbier Ann
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-21+40,000→ 40,000 totalExercise: $0.26Exp: 2033-06-21→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option will vest as to 100% of the underlying shares on the date of the Company's 2024 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.